abstract |
Inhibitors of HBV replication of formula (I), including stereochemical isomers thereof, and salts, hydrates, solvates, wherein A to E, R 1 , R 2 , R 3 and R 5 Has the meaning as defined herein. The present invention also relates to methods for producing said compounds, pharmaceutical compositions comprising them, and their use in HBV therapy alone or in combination with other HBV inhibitors. [Chemical 1] |